Legal & General Group
ELVN icon

Legal & General Group’s Enliven Therapeutics ELVN Stock Holding History

Legal & General Group’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Buy
33,083
+6,024
+22% +$167K ﹤0.01% 2055
2025
Q4 		$417K Sell
27,059
-6,706
-20% -$134K ﹤0.01% 2467
2025
Q3 		$691K Buy
33,765
+1,540
+5% +$31K ﹤0.01% 2345
2025
Q2 		$646K Buy
32,225
+11,058
+52% +$209K ﹤0.01% 2376
2025
Q1 		$417K Buy
21,167
+27
+0.1% +$581 ﹤0.01% 2451
2024
Q4 		$476K Buy
21,140
+812
+4% +$21K ﹤0.01% 2473
2024
Q3 		$519K Buy
20,328
+131
+0.6% +$3.03K ﹤0.01% 2451
2024
Q2 		$472K Sell
20,197
-448
-2% -$9.43K ﹤0.01% 2433
2024
Q1 		$363K Buy
20,645
+980
+5% +$15K ﹤0.01% 2548
2023
Q4 		$272K Hold
19,665
– – ﹤0.01% 2648
2023
Q3 		$269K Buy
19,665
+1,610
+9% +$27.1K ﹤0.01% 2648
2023
Q2 		$369K Buy
+18,055
New +$365K ﹤0.01% 2563
2021
Q2 		– Sell
-244
Closed -$8K – 3536
2021
Q1 		$8K Buy
244
+30
+14% +$1.52K ﹤0.01% 3426
2020
Q4 		$19K Buy
214
+58
+37% +$4.87K ﹤0.01% 3108
2020
Q3 		$13K Sell
156
-48
-24% -$4.33K ﹤0.01% 3121
2020
Q2 		$22K Buy
+204
New +$22.8K ﹤0.01% 3025

Other funds holding ELVN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return